SEC Form D · Amendment · filed November 20, 2024
Avenzo Therapeutics, Inc
Offering
$385.9M
Sold
$385.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (11)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗